(dinoprostone)

Prescribing Information
Download Prescribing Information

Health Professional Information

Contraindications

CONTRAINDICATIONS

Endocervically administered PREPIDIL Gel is not recommended for the following:

a.
Patients in whom oxytocic drugs are generally contraindicated or where prolonged contractions of the uterus are considered inappropriate, such as:
cases with a history of cesarean section or major uterine surgery
cases in which cephalopelvic disproportion is present
cases in which there is a history of difficult labor and/or traumatic delivery
grand multiparae with six or more previous term pregnancies cases with non-vertex presentation
cases with hyperactive or hypertonic uterine patterns
cases of fetal distress where delivery is not imminent
in obstetric emergencies where the benefit-to-risk ratio for either the fetus or the mother favors surgical intervention
b.
Patients with hypersensitivity to prostaglandins or constituents of the gel (see WARNINGS and ADVERSE REACTIONS).
c.
Patients with placenta previa or unexplained vaginal bleeding during this pregnancy.
d.
Patients for whom vaginal delivery is not indicated, such as vasa previa or active herpes genitalia.
Medication Guide
Download Consumer Medicine Information

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Additional Resources

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.

Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.

Available 9AM-5PM ET Monday to Friday; excluding holidays.

 

Submit a medical question for a Pfizer medicine or a vaccine. 

The submission will be reviewed during our standard business hours.

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information: 
Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.